TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor.

Vaibhav Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.